The Food stuff and Drug Administration mentioned today that next yesterday’s favourable advisory committee conference end result regarding the Pfizer-BioNTech COVID-19 vaccine, it would quickly do the job toward finalization and issuance of an emergency use authorization for the COVID-19 vaccine.
The Food and drug administration gave no precise timeline.
The agency has also notified the U.S. Facilities for Ailment Manage and Prevention and Procedure Warp Pace, so they can execute their options for timely vaccine distribution.
Find out on-demand, generate credit history, obtain goods and answers. Get Begun >>
Approval signifies vaccine distribution would be on Procedure Warp Speed’s schedule for distribution to entrance-line health care personnel and vulnerable populations in extended-term care facilities by mid-month.
The Food and drug administration advisory committee has scheduled an additional conference to evaluation the Moderna vaccine on Thursday, December seventeen.
See our continuing vaccine coverage here:
Pfizer-BioNTech vaccine gets Food and drug administration advisory committee approval
CMS provides guidance in billing Medicare for COVID-19 antibody treatment
1000’s in the United Kingdom are the initially to obtain Pfizer COVID-19 vaccine
Eli Lilly and UnitedHealth Group husband or wife on COVID-19 antibody treatment for large-possibility individuals
Procedure Warp Pace is on the lookout to start out distributing COVID-19 vaccine by mid-month
Moderna seeks regulatory authorization for its COVID-19 vaccine
HHS will start allocating Regeneron’s COVID-19 therapeutic this 7 days
HHS partners with chain and unbiased pharmacies to enhance obtain to long run COVID-19 vaccines
COVID-19 vaccine distribution will start within just 24 hours of an emergency use authorization
Moderna vaccine prospect reveals 94.5% efficacy towards COVID-19
Pfizer touts new COVID-19 vaccine, contacting it ‘90% effective’
Medicare beneficiaries can get monoclonal antibody COVID-19 solutions at no price
Food and drug administration grants emergency use authorization for Eli Lilly antibody treatment for COVID-19
Electronic mail the writer: [email protected]